Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥16,891,568 | CN¥20,545,832 | CN¥26,439,797 | CN¥28,767,425 |
| - Cash | CN¥6,999,423 | CN¥3,064,128 | CN¥4,591,309 | CN¥1,711,028 |
| + Debt | CN¥7,303,856 | CN¥1,623,745 | CN¥1,819,709 | CN¥1,372,935 |
| Enterprise Value | CN¥17,196,001 | CN¥19,105,449 | CN¥23,668,197 | CN¥28,429,333 |
| Revenue | CN¥8,547,477 | CN¥8,824,108 | CN¥13,038,948 | CN¥9,987,354 |
| % Growth | -3.1% | -32.3% | 30.6% | – |
| Gross Profit | CN¥537,181 | CN¥2,000,727 | CN¥5,546,731 | CN¥4,113,486 |
| % Margin | 6.3% | 22.7% | 42.5% | 41.2% |
| EBITDA | CN¥924,255 | CN¥2,409,894 | CN¥5,400,098 | CN¥4,281,552 |
| % Margin | 10.8% | 27.3% | 41.4% | 42.9% |
| Net Income | CN¥31,465 | CN¥1,283,244 | CN¥3,806,809 | CN¥3,018,471 |
| % Margin | 0.4% | 14.5% | 29.2% | 30.2% |
| EPS Diluted | 0.004 | 0.147 | 0.438 | 0.358 |
| % Growth | -97.5% | -66.3% | 22.3% | – |
| Operating Cash Flow | CN¥467,931 | CN¥80,332 | CN¥2,644,263 | CN¥3,196,718 |
| Capital Expenditures | -CN¥1,116,226 | -CN¥828,735 | -CN¥936,181 | -CN¥1,735,052 |
| Free Cash Flow | -CN¥648,295 | -CN¥748,404 | CN¥1,708,081 | CN¥1,461,667 |